BiotechTube
Home/Primo Biotechnology/Chi‑Wei Chang, Ph.D.
CC

Chi‑Wei Chang, Ph.D.

CTO, Radiopharmaceutical Chemistry

Primo Biotechnology

Therapeutic Areas

Oncology

Primo Biotechnology Pipeline

DrugIndicationPhase
Primo‑CR‑001Colorectal CancerPhase 1
PRIMO‑SOL‑ASolid TumorsPreclinical
PRIMO‑TB161‑001Various Solid TumorsPreclinical
Fludeoxyglucose F‑18PET Imaging (Oncology)Commercial

Leadership Team at Primo Biotechnology

JY
Joe Yeh, M.D.
Founder & Chairman
YH
Ya‑Yao Huang, Ph.D.
Founder & CEO
View full Primo Biotechnology profile